S&P 500 Futures
(0.36%) 5 110.00 points
Dow Jones Futures
(0.76%) 38 672 points
Nasdaq Futures
(0.63%) 17 761 points
Oil
(0.28%) $79.17
Gas
(-0.39%) $2.03
Gold
(-0.08%) $2 307.80
Silver
(-0.29%) $26.75
Platinum
(1.10%) $973.20
USD/EUR
(-0.19%) $0.930
USD/NOK
(-0.70%) $10.91
USD/GBP
(-0.17%) $0.797
USD/RUB
(0.55%) $91.63

Echtzeitaktualisierungen für Smith & Nephew SNATS Inc. [SNN]

Börse: NYSE Sektor: Healthcare Industrie: Medical - Devices
Zuletzt aktualisiert2 Mai 2024 @ 22:00

1.24% $ 24.44

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 22:00):
Profile picture for Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures...

Stats
Tagesvolumen 1.30M
Durchschnittsvolumen 954 109
Marktkapitalisierung 10.66B
EPS $0 ( 2024-02-27 )
Nächstes Ertragsdatum ( $0 ) 2024-08-01
Last Dividend $0.288 ( 2023-10-05 )
Next Dividend $0 ( N/A )
P/E 40.73
ATR14 $0.0120 (0.05%)

Volumen Korrelation

Lang: -0.71 (moderate negative)
Kurz: 0.18 (neutral)
Signal:(40.774) Neutral

Smith & Nephew SNATS Inc. Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Smith & Nephew SNATS Inc. Korrelation - Währung/Rohstoff

The country flag 0.27
( neutral )
The country flag 0.57
( weak )
The country flag 0.00
( neutral )
The country flag 0.11
( neutral )
The country flag -0.47
( neutral )
The country flag 0.67
( moderate )

Smith & Nephew SNATS Inc. Finanzdaten

Annual 2023
Umsatz: $5.55B
Bruttogewinn: $3.70B (66.70 %)
EPS: $0.600
FY 2023
Umsatz: $5.55B
Bruttogewinn: $3.70B (66.70 %)
EPS: $0.600
FY 2022
Umsatz: $5.22B
Bruttogewinn: $3.70B (70.85 %)
EPS: $0.510
FY 2021
Umsatz: $5.21B
Bruttogewinn: $3.67B (70.40 %)
EPS: $1.196

Financial Reports:

No articles found.

Smith & Nephew SNATS Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.288
(N/A)
$0
(N/A)
$0.462
(N/A)
$0
(N/A)
$0
(N/A)
$0.288
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Smith & Nephew SNATS Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.49 - Stable (10.24%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.139 2000-05-04
Last Dividend $0.288 2023-10-05
Next Dividend $0 N/A
Payout Date 2023-11-01
Next Payout Date N/A
# dividends 48 --
Total Paid Out $10.43 --
Avg. Dividend % Per Year 1.50% --
Score 4.34 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.49
Div. Directional Score 7.54 --
Next Divdend (Est)
(2024-09-30)
$0.288 Estimate 7.53 %
Dividend Stability
0.30 Poor
Dividend Score
4.34
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2000 $0.194 2.88%
2001 $0.146 1.58%
2002 $0.154 1.28%
2003 $0.169 1.36%
2004 $0.184 1.10%
2005 $0.194 0.96%
2006 $0.204 1.08%
2007 $0.223 1.07%
2008 $0.247 1.07%
2009 $0.271 2.08%
2010 $0.299 1.45%
2011 $0.328 1.56%
2012 $0.414 2.12%
2013 $0.532 2.39%
2014 $0.560 1.98%
2015 $0.608 1.69%
2016 $0.626 1.80%
2017 $0.616 2.05%
2018 $0.734 2.10%
2019 $0.728 2.00%
2020 $0.750 1.55%
2021 $0.750 1.75%
2022 $0.750 2.14%
2023 $0.750 2.75%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04751.5009.0510.00[0 - 0.5]
returnOnAssetsTTM0.02631.2009.1210.00[0 - 0.3]
returnOnEquityTTM0.05021.500-0.553-0.830[0.1 - 1]
payoutRatioTTM1.247-1.00010.00-10.00[0 - 1]
currentRatioTTM1.7750.8006.134.90[1 - 3]
quickRatioTTM0.6790.800-0.709-0.567[0.8 - 2.5]
cashRatioTTM0.1331.500-0.372-0.558[0.2 - 2]
debtRatioTTM0.294-1.5005.09-7.64[0 - 0.6]
interestCoverageTTM5.491.0009.089.08[3 - 30]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
freeCashFlowPerShareTTM0.4122.009.7910.00[0 - 20]
debtEquityRatioTTM0.564-1.5007.75-10.00[0 - 2.5]
grossProfitMarginTTM0.6881.0001.8621.862[0.2 - 0.8]
operatingProfitMarginTTM0.1371.0009.259.25[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2051.0009.979.97[0.2 - 2]
assetTurnoverTTM0.5530.8009.647.72[0.5 - 2]
Total Score10.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM40.621.0006.000[1 - 100]
returnOnEquityTTM0.05022.50-0.356-0.830[0.1 - 1.5]
freeCashFlowPerShareTTM0.4122.009.8610.00[0 - 30]
dividendYielPercentageTTM3.071.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
payoutRatioTTM1.2471.50010.00-10.00[0 - 1]
pegRatioTTM-1.5901.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1091.0009.770[0.1 - 0.5]
Total Score4.49

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.